Alnylam Pharmaceuticals Inc. (DUL)

331.39999 EUR

1.5

0.45%

Last update Dec 16, 7:55 PM CET

Market closed

Day range

331.39999

330

332.70001

Previous close

332.89999

Open

330

Access this stock data via API

Alnylam Pharmaceuticals Inc.

331.40

1.50

0.45%

Revenue estimate	Current quarter (Dec 2025)	Next quarter (Mar 2026)	Current year (Dec 2025)	Next year (Dec 2026)
Number of Analysts	20	10	25	24
Avg. estimate	1.18B	1.22B	3.75B	5.38B
Low estimate	1.08B	1.11B	3.42B	4.34B
High estimate	1.61B	1.31B	4.23B	6.12B
Last year sales	593.17M	594.19M	2.25B	3.75B
Sales growth	0.98	1.06	0.67	0.44

Access /revenue_estimate data via our API — starting from the Ultra plan.

EPS revisions	Current quarter (Dec 2025)	Next quarter (Mar 2026)	Current year (Dec 2025)	Next year (Dec 2026)
Up last 7 days	0	0	0	0
Up last 30 days	0	0	0	0
Down last 7 days	0	0	0	0
Down last 30 days	0	0	0	0

Access /eps_revisions data via our API — starting from the Ultra plan.

Access /recommendations data via our API — starting from the Ultra plan.

Access /analyst_ratings/light data via our API — starting from the Ultra plan.

Alnylam Pharmaceuticals Inc.